Tag Archive
Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today)
MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy. The application is based on the successful results of recent clinical trials involving patients with recurrent glioblastoma, an especially aggressive form of brain tumor… (read the story…) Related items MagForce Nanotechnologies... »
MagForce Nanotechnologies applies for EU regulatory approval of its Nano-Cancer therapy (News-Medical-Net)
MagForce Nanotechnologies AG, the Berlin-based medical nanotechnology company majority owned by Nanostart AG, has submitted its application for the European regulatory approval of its Nano-Cancer® therapy. (read the story…) Related items Nanostart-Owned MagForce Nanotechnologies AG: Application Submitted For EU Regulatory Approval Of Nano-Cancer(R) Therapy (Medical News Today) MagForce Nanotechnologies announces successful completion of its Nano-Cancer therapy trials (News-Medical-Net) Nanostart... »
MagForce Nanotechnologies AG Applies For European Regulatory Approval Of Its Nano-Cancer(R) Therapy (Medical News Today)
MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy… (read the story…) Related items MagForce Nanotechnologies initiates conformity assessment procedure... »
MagForce Nanotechnologies initiates conformity assessment procedure for its Nano-Cancer therapy (News-Medical-Net)
MagForce Nanotechnologies AG has submitted the product file for NanoTherm® to Medcert GmbH, the medical certification and testing company which serves as Notified Body for the certification of medical products. With this step, MagForce has now commenced the conformity assessment procedure for its Nano-Cancer ® therapy. (read the story…) Related items MagForce Nanotechnologies AG Applies For European... »
MagForce Nanotechnologies announces successful completion of its Nano-Cancer therapy trials (News-Medical-Net)
MagForce Nanotechnologies AG, the Berlin-based medical technology company majority owned by Nanostart AG, today announced the successful completion of final trials demonstrating the efficacy of its Nano-Cancer® therapy in patients with recurrent glioblastoma, a frequent form of brain tumor which is highly malignant. The actual study results significantly exceeded the study objective. (read the story…) Related... »
